Lv1
20 积分 2022-09-22 加入
Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor
2小时前
待确认
Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer
11天前
已完结
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
1个月前
已完结
The evolution of small molecule enzyme activators
2个月前
已完结
Connexins orchestrate progression of breast cancer metastasis to the brain by promoting FAK activation
2年前
已完结
皖公网安备34019202002308
